로딩 중…
지수 로딩 중…
Anavex Life Sciences Corp.
AVXL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$2.73+2.25%
2026-06-18
Price Chart
Anavex Life Sciences Corp.-69.77%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $253M |
| Revenue | $0.00 |
| Net Income | $-40M |
| Total Assets | $133M |
| Net Assets | $127M |
| Value | |
| P/B | 2.00x |
| FCF Yield | -13.47% |
| Profitability | |
| ROE | -31.55% |
| ROA | -30.04% |
| Financial Health | |
| Debt Ratio | 5.03% |
| Total Debt | $0.00 |
| FCF | $-34M |
| Cash | $132M |
| Current Ratio | 20.87x |
| Performance | |
| 1Y Return | -69.77% |
| 1M Return | 2.25% |
| From 52W High | -80.49% |
| 1Y MDD | -81.66% |
| Trading | |
| Volume | 5,590,548 shares |
| Trading Value | $15M |
| Per Share | |
| EPS | $-0.45 |
| BPS | $1.42 |